Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2007 1
2008 1
2011 1
2012 2
2013 2
2014 5
2015 2
2016 3
2017 3
2018 4
2019 3
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis.
Kiesewetter B, Lamm W, Dolak W, Lukas J, Mayerhoefer ME, Weber M, Schiefer AI, Kornauth C, Bayer G, Simonitsch-Klupp I, Raderer M. Kiesewetter B, et al. Among authors: lukas j. Br J Haematol. 2019 Aug;186(3):448-459. doi: 10.1111/bjh.15953. Epub 2019 May 24. Br J Haematol. 2019. PMID: 31124124 Free PMC article.
Treatment of mucosa associated lymphoid tissue lymphoma with a long-term once-weekly regimen of oral azithromycin: Results from the phase II MALT-A trial.
Lagler H, Kiesewetter B, Dolak W, Obermueller M, Simonitsch-Klupp I, Lukas J, Neuper O, Lamm WW, Mayerhoefer ME, Raderer M. Lagler H, et al. Among authors: lukas j. Hematol Oncol. 2019 Feb;37(1):22-26. doi: 10.1002/hon.2555. Epub 2018 Sep 19. Hematol Oncol. 2019. PMID: 30153341 Free PMC article. Clinical Trial.
Pre-Therapeutic Total Lesion Glycolysis on [18F]FDG-PET Enables Prognostication of 2-Year Progression-Free Survival in MALT Lymphoma Patients Treated with CD20-Antibody-Based Immunotherapy.
Mayerhoefer ME, Staudenherz A, Kiesewetter B, Weber M, Simonitsch-Klupp I, Gibbs P, Dolak W, Lukas J, Raderer M. Mayerhoefer ME, et al. Among authors: lukas j. Mol Imaging Biol. 2019 Dec;21(6):1192-1199. doi: 10.1007/s11307-019-01329-2. Mol Imaging Biol. 2019. PMID: 30847823 Free PMC article.
Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.
Mayerhoefer ME, Giraudo C, Senn D, Hartenbach M, Weber M, Rausch I, Kiesewetter B, Herold CJ, Hacker M, Pones M, Simonitsch-Klupp I, Müllauer L, Dolak W, Lukas J, Raderer M. Mayerhoefer ME, et al. Among authors: lukas j. Clin Nucl Med. 2016 Feb;41(2):101-5. doi: 10.1097/RLU.0000000000001005. Clin Nucl Med. 2016. PMID: 26402137 Free PMC article.
Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
Brammen L, Riss P, Lukas J, Gessl A, Dunkler D, Li S, Leisser A, Rezar-Dreindl S, Eibenberger K, Selberherr A, Scheuba C, Papp A. Brammen L, et al. Among authors: lukas j. Trials. 2018 Sep 15;19(1):495. doi: 10.1186/s13063-018-2876-0. Trials. 2018. PMID: 30219088 Free PMC article.
Immunohistochemical expression of cereblon and MUM1 as potential predictive markers of response to lenalidomide in extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
Kiesewetter B, Simonitsch-Klupp I, Kornauth C, Dolak W, Lukas J, Mayerhoefer ME, Raderer M. Kiesewetter B, et al. Among authors: lukas j. Hematol Oncol. 2018 Feb;36(1):62-67. doi: 10.1002/hon.2472. Epub 2017 Aug 22. Hematol Oncol. 2018. PMID: 28833354
27 results